FierceBiotech Feb 11, 2026 Moderna hit with FDA refusal-to-file letter for mRNA flu shot, issues sharp rebuke of agency's rationale
Endpoints News Feb 10, 2026 Moderna accuses FDA of shifting standard as agency refuses flu shot review
FierceBiotech Jan 30, 2026 Moderna offloads late-stage rare disease drug to Recordati for $50M upfront
FierceBiotech Jan 23, 2026 Anti-vaccine sentiment pushes Moderna away from new late-stage infectious disease trials
Moderna Jan 23, 2026 Anti-vaccine sentiment pushes Moderna away from new late-stage infectious disease trials - Fierce Biotech
eLife Jan 12, 2026 Dilated cardiomyopathy-associated RNA-binding motif protein 20 regulates long pre-mRNAs in neurons
FierceBiotech Dec 18, 2025 After HHS funding was scrapped, CEPI fronts up to $54M to carry Moderna's pandemic influenza vaccine into phase 3
Cell Dec 17, 2025 Distinct components of mRNA vaccines cooperate to instruct efficient germinal center responses
FierceBiotech Dec 5, 2025 'Unprecedented turmoil' engulfing FDA threatens public health: mRNA coalition speaks out